Xanthohumol Attenuated Inflammation and ECM Degradation by Mediating HO-1/C/EBPβ Pathway in Osteoarthritis Chondrocytes.

Saved in:
Bibliographic Details
Title: Xanthohumol Attenuated Inflammation and ECM Degradation by Mediating HO-1/C/EBPβ Pathway in Osteoarthritis Chondrocytes.
Authors: Zhang M; Department of Orthopedics, Taizhou People's Hospital, Taizhou, China., Zhang R; College of Pharmacy, Gannan Medical University, Ganzhou, China., Zheng T; Department of Orthopedics, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China., Chen Z; College of Pharmacy, Gannan Medical University, Ganzhou, China., Ji G; Department of Orthopedics, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China., Peng F; Department of Pathology, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China., Wang W; Department of Hepatology, Taizhou People's Hospital, Taizhou, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 May 04; Vol. 12, pp. 680585. Date of Electronic Publication: 2021 May 04 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2021.680585